$ABVE News

Why Above Food Ingredients (ABVE) Stock Fell 36% After Hours Today

Above Food Ingredients To Be Delisted From Nasdaq; Trading Suspended June 2, 2026 Over Missed Financial Filings

Above Food Provides Update On Status and Timing of Form 20 F Filing

Above Food Ingredients Inc. Provides Update on Completion of Fiscal 2025 Audit and Readiness to File Form 20-F

Above Food Ingredients Confirms Completion Of Audit Process, Prepares Form 20-F To Be Filed With SEC For FY25 Results

Above Food Ingredients Inc. Addresses Market Concerns

Above Food Ingredients Issues Statement In Response To Recent Market Speculation And Unusual Trading Activity In Its Shares

Above Food Ingredients Inc. Reporting Update

Above Food Ingredients (ABVE) Raises FY2026 Profit Outlook Above $40M

Above Food Ingredients Inc. Confirms January 2026 Release of Audited Fiscal 2025 Results, Highlights Strong Profitability and Clean Balance Sheet, and Announces Clear Path to Completion of Palm Global Merger

Above Food Expects FY25 Audited Results By January 2026; Reaffirms FY26 Profitability Ahead Of Palm Global Merger

Above Food Ingredients Inc. Provides Update on Fiscal 2025 Audit and Raises Fiscal 2026 Profit Guidance to over $40 Million

Why Is Above Food Stock Falling Today?

Above Food Ingredients Expects Fiscal 2025 Audit To Complete Shortly After New Year, Seeks 180-Day Nasdaq Extension, And Raises Fiscal 2026 Profit Guidance To Over $40M

Above Food Ingredients Expects Fiscal 2025 Audit To Complete Shortly After New Year, Seeks 180-Day Nasdaq Extension, And Raises Fiscal 2026 Profit Guidance To Over $40M

Above Food Eyes $30 Million Profit After Debt Reset

Above Food Ingredients, In Partnership With Palm Global, Eliminates Debt And Targets $30M FY26 Profit, Establishing Foundation For Sustainable Growth Despite FY25 Restructuring Loss

Above Food: Merger Intrigue Merits Extreme Caution

Above Food Secures $20M Convertible Note Investment From Aqua 1 At $2.50/Share; Proceeds To Advance Palm Global's Stablecoin And Tokenization Strategy

UBS Lowers the PT on Ambev S.A. (ABEV), Keeps a Neutral Rating